相关实验视频
Updated: Jun 26, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
252
塔莫西芬的使用作为双极性障碍的潜在治疗方法
Noy Bagdadi1, Abed N Azab2,3, Rachel Shvartsur2,3
1Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Israel.
Psychiatry and clinical psychopharmacology
|May 20, 2024
概括
塔莫西芬可能有助于减少双相情感障碍 (BD) 中的躁狂症状. 本综述审查了对他莫西芬的研究.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 双极性障碍 (BD) 是一种慢性精神疾病,复发率高,治疗效果有限.
- 现有的BD治疗方法经常失败,需要新的治疗方法.
- 塔莫西芬,以各种活动而闻名,正在研究潜在的BD治疗.
研究的目的:
- 审查前临床和临床研究,以查看塔莫西芬在治疗双极性躁狂症中的有效性.
- 阐明他莫西芬在BD中控制躁狂症状的治疗潜力.
主要方法:
- 临床前和临床研究的文献综述.
- 对研究他莫西芬对双相躁狂症的影响的研究分析.
主要成果:
- 塔莫西芬显示出作为减少双相情感障碍躁狂症状的治疗潜力.
- 拟议的机制涉及抑制蛋白激酶C (PKC).
结论:
- 塔莫西芬为双极性躁狂症提供了一个有前途的治疗选择.
- 需要进一步的研究,以充分理解他莫西芬在BD治疗中的作用.
相关概念视频
Mania and Antimanic Drugs: Overview
172
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
172
Antidepressant Drugs: MAOIs and Other Agents
225
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
225
Bipolar Disorder
67
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
370
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
370
Electroconvulsive Therapy
36
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
36
Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170

